EP-1352 Locally advanced NSCLC: performance status based eligibility for adjuvant check point inhibitorG. Persson,T. Schytte,A.L. Appelt, S. Borissova,C. Brink,T.S. Hansen,L. Hoffmann,M. Josipovic,A.A. Khalil,M.M. Knap,M.D. Lund,C.M. Lutz,D.S. Møller,T.B. Nielsen,M. Nielsen,W. Ottosson,M. Pøhl, J.B. Thomsen,O. HansenRadiotherapy and Oncology(2019)引用 0|浏览75暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要